Drug data last refreshed 5m ago · AI intelligence enriched 1w ago
NIZORAL is a topical antifungal shampoo containing ketoconazole, a small-molecule azole antifungal agent. It is indicated for the treatment of dandruff, seborrheic dermatitis, and other fungal scalp conditions. The drug works by disrupting fungal cell membrane synthesis through inhibition of lanosterol 14α-demethylase.
As a mature topical product approaching loss of exclusivity with moderate competitive pressure, teams are likely focused on cost management and market defense rather than expansion.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on NIZORAL offers limited career growth given the zero linked job postings and mature lifecycle stage. This role is best suited for professionals seeking stability in a well-established product or those transitioning into lifecycle management and cost optimization expertise.
Worked on NIZORAL at Johnson & Johnson? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.